Health Decisions to Participate in Important Reproductive Medicine Meeting
Durham, North Carolina. Health Decisions, Inc., the full-service clinical research organization of choice for forward-looking biopharma, diagnostics, precision medicine and medical device companies and a leader in women’s health studies, today announced its participation in the American Society for Reproductive Medicine Scientific Congress 2016 October 15-19 in Salt Lake City, UT. The theme of the 2016 ASRM Congress is “Scaling New Heights in Reproductive Medicine.”
“The Health Decisions contingent anticipates productive discussions with our many colleagues in the reproductive health community,” said Patrick Phillips, D.Phil., Health Decisions CEO. “This is a field in which rapid progress has markedly improved the lives of millions of individuals and couples worldwide. We are looking forward to learning about developments on the horizon in both reproductive therapeutics and diagnostics and to managing clinical studies that help bring additional improvements in patient health, reproductive success rates, acceptable options for contraception and quality of life.”
The program for the event outlines sessions addressing numerous key topics in reproductive medicine, including Assisted Reproduction Technology, long-acting reversible contraception, ovarian function and cardiovascular health, reproductive health in cancer survivors, biomarkers and emerging diagnostics in endometriosis, and “Managing the ‘Big Three’ in Infertility (Fibroids, Endometriosis, and Polycystic Ovary Syndrome).”
Sponsors and other colleagues in the reproductive health community are invited to schedule a discussion with a Health Decisions expert during or following ASRM on clinical development issues and opportunities for collaboration.
About Health Decisions
Health Decisions is the CRO of choice for forward-looking biopharma, diagnostics, precision medicine and medical device companies and a driving force in the modernization of clinical development. Health Decisions uses data-driven insight and agility to deliver clinical development success, reduce timelines and risk and increase quality and returns for biopharma, diagnostics and medical device companies worldwide. For more than 25 years and in more than 300 clinical trials involving tens of thousands of patients in many therapeutic areas, Health Decisions has improved the efficiency of clinical development through innovative methodology, processes and technology enabling developers of new therapeutics and diagnostics to bring new products to market faster and at lower cost, thus providing the public with earlier access to improved treatments and diagnostics at more affordable prices. Health Decisions is headquartered in Durham, NC and operates on five continents.
# # #
Senior Marketing Specialist
+1 919.967.1111 ext. 520
lhammill @ healthdec.com